Shake Shack Plunges, DataDog Soars, Citigroup Drops on ‘Underwhelming’ New Profitability Target

Shake Shack Plunges, DataDog Soars, Citigroup Drops on ‘Underwhelming’ New Profitability Target

On this episode of Stock Movers:
- Shake Shack (SHAK) shares plummeted after the burger chain reported first-quarter revenue that missed expectations due to pressures including rising beef costs and inclement weather. The company reported revenue of $366.7 million, below the analyst estimate for $372.5 million, and comparable sales growth of 4.6% was roughly in line with expectations.
- DataDog (DDOG) shares surged by the most in more than six years after the software developer raised its full-year outlook for sales and earnings. Revenue is now expected to total $4.3 billion to $4.34 billion, above analysts’ estimates of $4.09 billion on average. Datadog Chief Executive Officer Olivier Pomel said the company is "aggressively building with and for AI", and has signed deals with "two of the world’s biggest AI research teams" to help them with their training workflows.
- Citigroup (C) shares drop. Citigroup Inc. issued new guidance showing it would take the lender more time to catch up to Wall Street peers, with a return on tangible common equity of about 14% to 15% by 2031. The bank's guidance was described as "underwhelming" by some analysts, with investors having looked for a "more aspirational" target of 15% or more over the medium term.

See omnystudio.com/listener for privacy information.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(2204)

Biogen to Buy Apellis; Lilly to Buy Sleep Drug Maker; Nvidia Invests $2 Billion in Marvell

Biogen to Buy Apellis; Lilly to Buy Sleep Drug Maker; Nvidia Invests $2 Billion in Marvell

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Biogen (BIIB) has agreed to acquire Apellis Pharmaceuticals Inc. for $5.6 billion, expanding its treatments i...

31 Mar 3min

Lilly to Buy Centessa Pharmaceuticals; Biogen to Buy Apellis; Unilever Foods Exit

Lilly to Buy Centessa Pharmaceuticals; Biogen to Buy Apellis; Unilever Foods Exit

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- Lilly (LLY) to buy Centessa Pharmaceuticals for $38/share in cash plus one non-transferrable contingent value r...

31 Mar 4min

LVMH Falls, Future Slumps, Dermapharm Drops

LVMH Falls, Future Slumps, Dermapharm Drops

On this episode of Stock Movers:- LVMH, SAP, and Novo Nordisk have slumped by about 30% so far this year, making up about 53% of the total market capitalization shed by constituents of the Stoxx Europ...

31 Mar 4min

LVMH Falls, Future Slumps, Getlink Rises

LVMH Falls, Future Slumps, Getlink Rises

Today's biggest winners and losers in the stock market.On this episode of Stock Movers:- LVMH, SAP, and Novo Nordisk have slumped by about 30% so far this year, making up about 53% of the total market...

31 Mar 4min

Cybersecurity Bounces Back, Sysco Sinks, Fannie and Freddie Surges

Cybersecurity Bounces Back, Sysco Sinks, Fannie and Freddie Surges

On this episode of Stock Movers:- Shares of security software companies are rising on Monday, with the group rebounding in the wake of recent weakness, which had been spurred by concerns over AI-relat...

30 Mar 5min

Closing Bell: Boston Scientific Tumbles, Aluminum Stocks Soar, Fannie/Freddie Surges

Closing Bell: Boston Scientific Tumbles, Aluminum Stocks Soar, Fannie/Freddie Surges

On this episode of Stock Movers:Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Bailey Lipshultz, Katie Grei...

30 Mar 5min

Boston Scientific Tumbles, Sysco Sinks, Fannie and Freddie Surges

Boston Scientific Tumbles, Sysco Sinks, Fannie and Freddie Surges

On this episode of Stock Movers:- Boston Scientific (BSX) shares tumble as much as 11%, the most intraday since February 4, after results from the medical device maker’s trial of the Watchman heart im...

30 Mar 4min

Expedia Rises, Sysco Falls, Viridian Therapeutics Tumbles as Eye Drug’s Efficacy Data Fall Short

Expedia Rises, Sysco Falls, Viridian Therapeutics Tumbles as Eye Drug’s Efficacy Data Fall Short

On this episode of Stock Movers: - Expedia (EXPE) gains and Instacart rises. Jefferies upgraded both to buy, saying a pullback in internet stocks on concerns about artificial intelligence disruptions ...

30 Mar 4min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
forklart
aftenpodden-usa
stopp-verden
fotballpodden-2
nokon-ma-ga
popradet
rss-gukild-johaug
det-store-bildet
dine-penger-pengeradet
lydartikler-fra-aftenposten
rss-espen-lee-usensurert
rss-ness
hanna-de-heldige
aftenbla-bla
rss-dannet-uten-piano
grasoner-den-nye-kalde-krigen
e24-podden
rss-utenrikskomiteen-med-bogen-og-grasvik